Tag: Valeant Pharmaceuticals International
May 1, 2017
Valeant Announces Debt Reduction
Valeant Pharmaceuticals International announced a $220 million reduction in its debt thanks to a skincare brand sale and an international... April 26, 2017
Valeant's Subsidiary Earns FDA Clearance
Valeant Pharmaceuticals announced its owned subsidiary Bausch + Lomb received FDA clearance for Vitesse. April 21, 2017